Ken Furuya
- Co-authors
- Masashi OheHouman GoudarziHaruki ShidaYoshihiro KusunokiSatoshi JodoKazuo TamuraManabu TakeuchiYoshinori Munemoto
- Topics
- Liver Disease Diagnosis and Treatment (7 papers)Ovarian cancer diagnosis and treatment (4 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Ken Furuya
28 papers receiving 314 citations
Peers
Comparison fields: 5 of 66
- Physiology 95
- Epidemiology 87
- Molecular Biology 64
- Hepatology 61
- Oncology 55
Countries citing papers authored by Ken Furuya
This map shows the geographic impact of Ken Furuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Furuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Furuya more than expected).
Fields of papers citing papers by Ken Furuya
This network shows the impact of papers produced by Ken Furuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Furuya. The network helps show where Ken Furuya may publish in the future.
Co-authorship network of co-authors of Ken Furuya
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Furuya. A scholar is included among the top collaborators of Ken Furuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Furuya. Ken Furuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 15 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 0 | |
| 15 | Normal serum CA125 half-life and normal serum nadir CA125 level in patients with ovarian cancers. | 6 |
| 16 | 18 | |
| 17 | 4 | |
| 18 | 11 | |
| 19 | [Evaluation method of surgical margin in musculoskeletal sarcoma]. | 7 |
| 20 | Review of 240 gastroscopic biopsies and smear test. | 1 |
About Ken Furuya
Ken Furuya is a scholar working on Applied Microbiology and Biotechnology, Hepatology and Reproductive Medicine, having authored 33 papers that have together received 320 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Ovarian cancer diagnosis and treatment (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Hepatology (61 citations), Geriatrics and Gerontology (16 citations) and Applied Microbiology and Biotechnology (8 citations). Ken Furuya has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Masashi Ohe, Houman Goudarzi, Haruki Shida, Yoshihiro Kusunoki, Satoshi Jodo, Kazuo Tamura, Manabu Takeuchi, Yoshinori Munemoto, Takashi Higashiguchi and Hideo Baba. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.